Log in

LON:GDR - Genedrive Share Price, Forecast & News

GBX 20
-1.50 (-6.98 %)
(As of 12/16/2019 07:19 AM ET)
Today's Range
20
Now: GBX 20
20
50-Day Range
16
MA: GBX 19.99
24.20
52-Week Range
13
Now: GBX 20
30
Volume250 shs
Average Volume9,606 shs
Market Capitalization£6.80 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. It operates through three divisions: Preclinical Research Services, Pharmacogenomic Services, and Diagnostics. The Preclinical Research Services division provides pre-clinical testing services in the areas of oncology, oncology supportive care, inflammatory bowel disease, leukaemia, gastrointestinal disease, inflammation, skin care and wound healing, and rheumatoid arthritis. Read More…

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+44-161-9890245

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£2.36 million
Cash FlowGBX 14.23 per share
Book ValueGBX (7.30) per share

Profitability

Miscellaneous

Employees72
Market Cap£6.80 million
Next Earnings DateN/A
OptionableNot Optionable

Receive GDR News and Ratings via Email

Sign-up to receive the latest news and ratings for GDR and its competitors with MarketBeat's FREE daily newsletter.


Genedrive (LON:GDR) Frequently Asked Questions

What is Genedrive's stock symbol?

Genedrive trades on the London Stock Exchange (LON) under the ticker symbol "GDR."

How were Genedrive's earnings last quarter?

Genedrive PLC (LON:GDR) posted its earnings results on Tuesday, March, 20th. The company reported ($9.00) earnings per share for the quarter. The business earned $2.63 million during the quarter. View Genedrive's Earnings History.

What is the consensus analysts' recommendation for Genedrive?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genedrive in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Genedrive.

Has Genedrive been receiving favorable news coverage?

Press coverage about GDR stock has been trending somewhat negative recently, according to InfoTrie Sentiment. The research group ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Genedrive earned a media sentiment score of -1.7 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the stock's share price in the immediate future. View News Stories for Genedrive.

Who are some of Genedrive's key competitors?

What other stocks do shareholders of Genedrive own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Genedrive investors own include NVIDIA (NVDA), Allena Pharmaceuticals (ALNA), Chuy's (CHUY), Comtech Telecomm. (CMTL), Cisco Systems (CSCO), FormFactor (FORM), Hub Group (HUBG), Mondelez International (MDLZ), Methanex (MEOH) and Manitex International (MNTX).

Who are Genedrive's key executives?

Genedrive's management team includes the folowing people:
  • Mr. David Budd, CEO & Director (Age 51)
  • Mr. Matthew J. Fowler, CFO, Company Sec. & Director (Age 44)

How do I buy shares of Genedrive?

Shares of GDR and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Genedrive's stock price today?

One share of GDR stock can currently be purchased for approximately GBX 20.

How big of a company is Genedrive?

Genedrive has a market capitalization of £6.80 million and generates £2.36 million in revenue each year. Genedrive employs 72 workers across the globe.View Additional Information About Genedrive.

What is Genedrive's official website?

The official website for Genedrive is http://www.genedriveplc.com/.

How can I contact Genedrive?

Genedrive's mailing address is 48 Grafton Street, MANCHESTER, M13 9XX, United Kingdom. The company can be reached via phone at +44-161-9890245.


MarketBeat Community Rating for Genedrive (LON GDR)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  210 (Vote Outperform)
Underperform Votes:  161 (Vote Underperform)
Total Votes:  371
MarketBeat's community ratings are surveys of what our community members think about Genedrive and other stocks. Vote "Outperform" if you believe GDR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GDR will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel